In a recently accepted manuscript titled “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data”, scientists from Insilico ...
Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
For decades, the phrase “incurable disease” has been considered a cold, impenetrable and definitive wall in medical sciences. In the room where the word “incurable” ...
Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...
A doctor-tech leader from India argues that genomic data infrastructure, resistance forecasting and sovereign AI discovery tools will be critical to future regional pandemic response.
Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.